Serum levels of angiopoietin-1 in patients with pulmonary hypertension due to mitral stenosis

Heart and Vessels

Volumn 26, Issue 5, 2011, Pages 536-541

  Karapinar, Hekim ^a   Esen, Ozlem ^b,d   Emiroǧlu, Yunus ^c   Akçakoyun, Mustafa ^c   Pala, Selçuk ^c   Kargin, Ramazan ^c   Izgi, Akin ^c   Kirma, Cevat ^c   Esen, Ali Metin ^c  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^b MEMORIAL HOSPITAL   (Turkey)

^c Department of Cardiovascular Surgery Anesthesiology and Reanimation   (Turkey)

^d Barbaros Mh Ihlamur Sk Uphill Court Sitesi   (Turkey)

Author keywords

Angiopoietin 1; Mitral stenosis; Pulmonary hypertension

Indexed keywords

ANGIOPOIETIN 1; ANGPT1 PROTEIN, HUMAN; BIOLOGICAL MARKER;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; DOWN REGULATION; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PULMONARY ARTERY; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TURKEY (REPUBLIC);

ADULT; ANALYSIS OF VARIANCE; ANGIOPOIETIN-1; BIOLOGICAL MARKERS; BLOOD PRESSURE; DOWN-REGULATION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; MITRAL VALVE STENOSIS; PREDICTIVE VALUE OF TESTS; PULMONARY ARTERY; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TURKEY;

EID: 84855726652     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-010-0092-2     Document Type: Article

References (23)

1. Fujita H, Fukumoto Y, Saji K, Sugimura K, Demachi J, Nawata J, Shimokawa H (2010) Acute vasodilator effects of inhaled fasudil, a specific Rho-kinase inhibitor, in patients with pulmonary arterial hypertension. Heart Vessels Mar 25(2):144-149
2. Qi J, Du J, Tang X, Li J, Wei B, Tang C (2004) The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting. Heart Vessels Mar 19(2):81-88
3. Collados MT, Velázquez B, Borbolla JR, Sandoval J, Massó F, Montaño LF, Guarner V (2003) Endothelin-1, functional tissue factor: a possible relationship with severity in primary pulmonary hypertension. Heart Vessels Mar 18(1):12-17
4. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD (1996) Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87:1161-1169 (Pubitemid 27010100)
5. Kim KT, Choi HH, Steinmetz MO, Maco B, Kammerer RA, Ahn SY, Kim HZ, Lee GM, Koh GY (2005) Oligomerization and multimerization are critical for angiopoietin-1 to bind and phosphorylate Tie2. J Biol Chem 280:20126-20131 (Pubitemid 41379543)
6. Thistlethwaite PA, Lee SH, Du LL, Wolf PL, Sullivan C, Pradhan S, Deutsch R, Jamieson SW (2001) Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg 122:65-73
7. Abdulmalek K, Ashur F, Ezer N, Ye F, Magder S, Hussain SN (2001) Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats. Am J Physiol Lung Cell Mol Physiol 281:L582-L590
8. Sato TN, Tozawa Y, Deutsch U, Wolburg-Buchholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y (1995) Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376:70-74
9. Wong AL, Haroon ZA, Werner S, Dewhirst MW, Greenberg CS, Peters KG (1997) Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81:567-574 (Pubitemid 27432744)
10. Du L, Sullivan CC, Chu D, Cho AJ, Kido M, Wolf PL, Yuan JX, Deutsch R, Jamieson SW, Thistlethwaite PA (2003) Signaling molecules in nonfamilial pulmonary hypertension. N Engl J Med 348:500-509 (Pubitemid 36159885)
11. Zhao YD, Campbell AIM, Robb M, Ng D, Stewart DJ (2003) Protective role of angiopoietin-1 in experimental pulmonary hypertension. Circ Res 92:984-991 (Pubitemid 36588497)
12. Oudiz RJ (2007) Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med 28:233-241
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18(12):1440-1463 (Pubitemid 41821197)
14. Kircher BJ, Himelman RB, Schiller NB (1990) Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 66(4):493-496 (Pubitemid 20259386)
15. Otto CM (2004) Left and right ventricular systolic function. In: Otto CM (ed) Textbook of clinical echocardiography. Elsevier Saunders, Philadelphia, pp 131-165
16. Sullivan CC, Du L, Chu D, Cho AJ, Kido M, Wolf PL, Jamieson SW, Thistlethwaite PA (2003) Induction of pulmonary hypertension by an angiopoietin-1/TIE2/serotonin pathway. Proc Natl Acad Sci USA 100:12331-12336 (Pubitemid 37271560)
17. Kümpers P, Nickel N, Lukasz A, Golpon H, Westerkamp V, Olsson KM, Jonigk D, Maegel L, Bockmeyer CL, David S, Hoeper MM (2010) Circulating angiopoietins in idiopathic pulmonary arterial hypertension. Eur Heart J 31:2291-2300
18. Kugathasan L, Dutly AE, Zhao YD, Deng Y, Robb MJ, Keshavjee S, Stewart DJ (2005) Role of Angiopoietin-1 in experimental and human pulmonary arterial hypertension. Chest 128:633S-642S (Pubitemid 43054177)
19. Yamamoto A, Takahashi H, Kojima Y, Tsuda Y, Morio Y, MuramatsuM, FukuchiY(2008)Downregulation ofAngiopoietin-1 and Tie2 in chronic hypoxic pulmonary hypertension. Respiration 75:328-338 (Pubitemid 351450405)
20. Kugathasan L, Ray JB, Deng Y, Rezaei E, Dumont DJ, Stewart DJ (2009) The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice. J Exp Med 206(10):2221-2234
21. Abramson SV, Burke JF, Kelly JJ Jr, Kitchen JG 3rd, Dougherty MJ, Yih DF, McGeehin FC 3rd, Shuck JW, Phiambolis TP (1992) Pulmonary hypertension predicts mortality and morbidity in patients with dilated cardiomyopathy. Ann Intern Med 116: 888-895 (Pubitemid 23034779)
22. Zener JC, Hancock EW, Shumway NE, Harrison DC (1972) Regression of extreme pulmonary hypertension after mitral valve surgery. Am J Cardiol 30:820-826
23. Braunwald E, Braunwald NS, Ross J Jr, Morrow AG (1965) Effects of mitral-valve replacement on the pulmonary vascular dynamics of patients with pulmonary hypertension. N Engl J Med 273:509-514